Responsible Manufacturing Can Help Curb Drug Resistance

The report looks at pharmaceutical companies’ management of waste from their antibiotic production. Alongside overuse and misuse of antibiotics, as well as lack of access to appropriate antibiotics, antibiotic waste discharged into the environment is a driver of antimicrobial resistance (AMR), which directly contributed to the deaths of 1.27 million people in 2019 alone. 

The article focuses on the three areas the report recommends for companies: the need to employ effective methods to limit AMR risks; the need to promote compliance with discharge limits across the antibiotic supply chain; and the need to disclose actions transparently.

Read the Foundation's report on responsible manufacturing.